跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
neuroinflammation therapy
首页
药物
neuroinflammation therapy
neuroinflammation therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PET VISUALIZATION OF AMYLOID-ASSOCIATED NEUROINFLAMMATION IN THE BRAIN
EP 2120717 A1
申请人: NAT INST RADIOLOG
优先权: 2007
EP
US
WO
3 件公开
Use of bowman birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases
US 2002127289 A1
申请人: UNIV PENNSYLVANIA
优先权: 2001
US
3 件公开
CRISPR-CAS9 MEDIATED DISRUPTION OF ALCAM GENE INHIBITS ADHESION AND TRANS-ENDOTHELIAL MIGRATION OF MYELOID CELLS
US 2023220361 A1
申请人: UNIV TEMPLE
优先权: 2020
US
WO
2 件公开
Use of negative functional modulators of erythropoietin for therapy
US 11078270 B2
申请人: ANDREMACON S R L
优先权: 2014
US
Combination therapy of stem cell mobilizing agents and stem cell transplantation
US 10130683 B1
申请人: BORLONGAN CESARIO VENTURINA
优先权: 2015
US
Methods of treating CART-T cell therapy-induced neuroinflammation using a GM-CSF antagonist
US 11130805 B2
申请人: HUMANIGEN INC
优先权: 2019
US
Fusion protein containing IL13
CN 114144194 A
申请人: PRIVATE LTD RESPONSIBILITY COMPANY FOR SNAKEEN PHARMACY
优先权: 2019
CN
Application of CD177 anti-inflammatory neutrophil in treatment of cerebral arterial thrombosis
CN 117085039 A
申请人: RENJI HOSPITAL SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE
优先权: 2022
CN
METHODS FOR TREATING NEUROINFLAMMATION
US 20250319139 A1
申请人: UNIV VIRGINIA PATENT FOUNDATION
优先权: 2022
US
Compositions and methods for treating alzheimer's disease and other brain diseases
CN 120303007 A
申请人: UNIV TEXAS
优先权: 2022
CN
第 1 / 3 页
上一页
下一页
药物
反馈